StonvexLoading…
StonvexStonvexStonvexCore line items from HOPE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $230.14M | $941.16M | $244.70M | $239.09M |
Operating Income | $37.92M | $77.28M | $36.37M | $-26.07M |
Net Income | $29.54M | $61.59M | $30.78M | $-24.75M |
EPS (Diluted) | $0.23 | $0.49 | $0.24 | $-0.19 |
Total Assets | $18.66B | $18.53B | $18.51B | $18.55B |
Total Liabilities | $16.37B | $16.25B | $16.25B | $16.32B |
Cash & Equivalents | $594.77M | $560.06M | $454.91M | $689.73M |
Free Cash Flow OCF − CapEx | $11.80M | $151.46M | $78.07M | $30.90M |
Shares Outstanding | 127.82M | 128.20M | 128.19M | 128.12M |